VAXART (VXRT)
(Delayed Data from NSDQ)
$0.66 USD
+0.05 (8.12%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $0.66 0.00 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VXRT 0.66 +0.05(8.12%)
Will VXRT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for VXRT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VXRT
Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?
VXRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Top-Ranked Stocks That Have More Than Doubled Year to Date
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?
Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now
Other News for VXRT
Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
Vaxart anticipates funds to extend its cash runway into 2026